Status:
COMPLETED
Trial to Evaluate the Efficacy of Fluvastatin on Certain Markers
Lead Sponsor:
Novartis
Conditions:
Dyslipidemia
Eligibility:
All Genders
18-75 years
Phase:
PHASE4
Brief Summary
To analyze efficacy of fluvastatin on patients with chronic renal disease by analyzing certain inflammatory markers. In addition, tolerability and safety will also be evaluated in a Spanish population...
Eligibility Criteria
Inclusion
- Patients \> 18 years Patients that give their inform consent
Exclusion
- Pregnant women Diabetic patients Treated with statins for the year prior to study inclusion Patients with contraindications listed in fluvastatin prescribing information
- Other protocol-defined in and exclusion criteria may apply
Key Trial Info
Start Date :
August 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2007
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT00171262
Start Date
August 1 2004
End Date
June 1 2007
Last Update
February 23 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Novartis
Madrid, Spain